Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats-Reference-Cited by-同舟云学术

Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats

Published:2010-09-06 Issue:11 Volume:44 Page:1369-1377
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Arozal Wawaimuli,Watanabe Kenichi,Veeraveedu Punniyakoti T.,Thandavarayan Rajarajan A.,Harima Meilei,Sukumaran Vijayakumar,Suzuki Kenji,Tachikawa Hitoshi,Kodama Makoto,Aizawa Yoshifusa

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

http://www.tandfonline.com/doi/pdf/10.3109/10715762.2010.509399

Reference38 articles.

1. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

2. Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

3. Daunorubicin-Induced Apoptosis in Rat Cardiac Myocytes Is Inhibited by Dexrazoxane

4. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

5. Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea;PLOS ONE;2023-11-20

2. Molecular mechanisms of endothelial remodeling under doxorubicin treatment;Biomedicine & Pharmacotherapy;2023-06

3. Novel Therapeutics for Anthracycline Induced Cardiotoxicity;Frontiers in Cardiovascular Medicine;2022-04-22

4. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells;Toxicology and Applied Pharmacology;2022-01

5. NOXA‐mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin‐treated human acute myeloid leukemia cells;Journal of Cellular Physiology;2021-05-13